Thyroid-Associated Orbitopathy: Who and How to Treat
- 1 June 2009
- journal article
- review article
- Published by Elsevier in Endocrinology and Metabolism Clinics of North America
- Vol. 38 (2) , 373-388
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Is orbital decompression a safe and effective treatment for Graves' orbitopathy?Nature Clinical Practice Endocrinology & Metabolism, 2007
- Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) surveyBritish Journal of Ophthalmology, 2006
- A questionnaire survey on the management of Graves’ orbitopathy in EuropeEuropean Journal of Endocrinology, 2006
- Pathogenesis of Graves Ophthalmopathy: Implications for Prediction, Prevention, and TreatmentAmerican Journal of Ophthalmology, 2006
- Medial Wall Decompression For Optic Neuropathy But Lateral Wall Decompression With Fat Removal For Non Vision-Threatening IndicationsAmerican Journal of Ophthalmology, 2006
- Measuring disease activity to predict therapeutic outcome in Graves’ ophthalmopathyClinical Endocrinology, 2005
- The Effect of Müllerectomy on Kocher SignOphthalmic Plastic & Reconstructive Surgery, 2001
- Does Decompression Diminish the Discomfort of Severe Dysthyroid Orbitopathy?Ophthalmic Plastic & Reconstructive Surgery, 1995
- Prednisone and Cyclosporine in the Treatment of Severe Graves' OphthalmopathyNew England Journal of Medicine, 1989
- Ciclosporin and prednisone v. prednisone in treatment of Graves' ophthalmopathy: a controlled, randomized and prospective studyEuropean Journal of Clinical Investigation, 1986